StonvexLoading…
StonvexStonvexStonvexCore line items from TTD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $688.86M | $2.90B | $2.05B | $1.31B |
Operating Income | $66.65M | $589.32M | $332.45M | $171.23M |
Net Income | $40.00M | $443.30M | $256.35M | $90.13M |
EPS (Diluted) | $0.08 | $0.90 | $0.52 | $0.28 |
Total Assets | $5.73B | $6.15B | $5.94B | $5.96B |
Total Liabilities | $3.28B | $3.67B | $3.34B | $3.26B |
Cash & Equivalents | $878.38M | $658.17M | $653.13M | $896.39M |
Free Cash Flow OCF − CapEx | $279.06M | $795.71M | $510.44M | $352.09M |
Shares Outstanding | 476.88M | 493.55M | 497.20M | 499.34M |